Patient Reported Outcomes
Evaluating the Evidence for EMEA Treatment Satisfaction Claims
Annabel Nixon PhD, Nuz Quadri MSc & Katy Gallop MSc
Evaluating Clinician Reported Outcomes (ClinROs) as Endpoints for FDA Regulatory Approvals
Nixon A and Gallop K
PRO Recall Periods in Light of the Final FDA Guidance
Annabel Nixon PhD, Diane Wild MSc
The Translation and Linguistic Validation of the EQ-5D Electronic Version (EQ-5D ePRO)
Ashcroft-Jones A, Furtado T, Wild D.J.
Classifying patient reported outcomes: Developments in the field suggest a new taxonomy
Andrew J. Lloyd, John F P Bridges PhD, F. Reed Johnson
Conceptualizing disease: building unifying models to support the development of PROs and cost-effectiveness analyses. A case study in Alzheimer’s Disease (AD)
Wild D, Mealing S, Gallop K, Nixon A, Lloyd A, Briggs A, Sculpher M
Difficulties with the application of PRO measures to cultures outside of Western Europe and North America in multi-national trials
Furtado T, Houchin C, Wild D.
Qualitative methods in PRO research: development of a methods matrix
Nixon A, Wild D & Kerr C,
A novel comparison of qualitative data sources: content analysis of semi-structured patient interviews versus weblogs (blogs)
Acaster, S and Wild, D.
The impact of Lennox-Gastaut Syndome (LGS) on health related quality of life - a conceptual model
Verdian, L. Gallop, K., Wild, D, Falconer S.
Utilities for Infusion Therapy in Type Diabetes
Andrew J. Lloyd, Paul Swinburn, Kristina S. Boye , Bradley Curtis , Eric Sarpong , Kim Goldsmith, Bruce Bode, Stephen Aronoff
Health State Utility Values For Atrial Fibrillation and Associated Treatment-Related Adverse Events
Scott Doyle, Andrew Lloyd, Ann-Marie Craig, Mark Davis.
The Suitability of Visual Analogue Scales (VAS) for Collecting Patient-Reported Outcomes (PRO) Data from International Settings
Houchin C , Nixon A , Herdman M, Juárez D, Labuschagne L, Manuel C, Manuel F,
Sanz D, Wan Mahmud WMR6, Gallop K .
Validation of the Sinonasal Outcome Test-16 (SNOT-16) in patients with acute bacterial sinusitis
Andrew Lloyd DPhil, Kerstin Uhl-Hochgräber PhD ; Jay Piccirillo, MD, FACS
Validation of the Activity Impairment Assessment in patients with acute bacterial sinusitis
Andrew Lloyd, Kerstin Uhl-Hochgräber; Karen Keating
Quality of life impact of men having hot flushes of men receiving treatment for prostate cancer
Nixon A., Swinburn P., Lloyd A., Connelly M.
MAKING TREATMENT BENEFIT CLAIMS TO THE FDA; The Role of, and Interrelationships between, Conceptual Models, Endpoint Models and Conceptual Frameworks
Diane Wild, Christina Donatti, Asha Hareendran
Methodologies for assessing and demonstrating data saturation in Qualitative inquiry supporting patient-reported outcomes research
Nixon A, Wild D
Societal Preferences (Utilities) for Advanced Melanoma Health States in the UK and Australia
Shelagh M. Szabo, Kathy Beusterien, Srividya Kotapati, Jayanti Mukherjee, Axel Hoos, Adrian R Levy ,
Supporting Product Label Claims in Drug Development: A Framework for Integrating Patient Reported Outcomes and Health Economic Concepts and Endpoints
Donatti C., Wild D., Nixon A., Briggs A., Sculpher M.
Patient-Informant Agreement on a Multidimensional Measure of Cognitive Impairment and Its Impact on Health-Related Quality of Life
Louis S. Matza ; Jennifer A. Flynn; Lori Frank ; Leah Kleinman ; Lee Bowman; Roger Bullock
Insight to Impact of Mild Cognitive Impairment and Early Alzheimer’s Disease
Jennifer A. Flynn, Lori Frank, Andrew Lloyd, Louis Matza, Lee Bowman
Validation of a New Patient-Reported Outcomes Instrument for Cognitive Impairment
Lori Frank; Jennifer A. Flynn; Mary Kay Margolis; Leah Kleinman; Louis S. Matza; Lee Bowman
Comparison of Informant and Neuropsychological Ratings of Cognitive Impairment
Leah Kleinman; Lori Frank; Louis S. Matza; Jennifer A. Flynn; Lee Bowman